Peng Shi Selected Research

Familial Periodic Paralyses (Normokalemic Periodic Paralysis)

9/2020

Identification of a SCN4A mutation in a large Chinese family with atypical normokalemic periodic paralysis using whole-exome sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peng Shi Research Topics

Disease

25	Neoplasms (Cancer) 06/2022 - 10/2008
15	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2008
12	Inflammation (Inflammations) 05/2022 - 10/2015
12	Hypertension (High Blood Pressure) 04/2022 - 09/2008
9	Fibrosis (Cirrhosis) 12/2021 - 01/2016
7	Infections 06/2022 - 05/2014
5	Rhinosinusitis 09/2012 - 11/2006
4	Papillary Thyroid Cancer 06/2022 - 03/2020
4	Neoplasm Metastasis (Metastasis) 04/2022 - 03/2018
4	Wounds and Injuries (Trauma) 01/2020 - 06/2014
4	Intervertebral Disc Degeneration 01/2019 - 03/2013
4	Nasal Polyps (Nasal Polyp) 11/2011 - 11/2006
3	Necrosis 05/2022 - 02/2008
3	Hypoxia (Hypoxemia) 01/2022 - 01/2018
3	Fever (Fevers) 06/2021 - 01/2015
3	Pain (Aches) 06/2021 - 03/2012
3	Melanoma (Melanoma, Malignant) 01/2021 - 09/2014
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2019
3	Back Pain (Backache) 12/2020 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2017
3	Cicatrix (Scar) 01/2020 - 11/2018
3	Neuroinflammatory Diseases 01/2017 - 08/2015
3	Septic Shock (Toxic Shock Syndrome) 11/2011 - 01/2008
2	Rheumatoid Arthritis 10/2022 - 12/2020
2	Carcinoma (Carcinomatosis) 02/2022 - 05/2008
2	Pediatric Crohn's disease 01/2022 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2020
2	Ischemic Stroke 01/2021 - 06/2017
2	Crohn Disease (Crohn's Disease) 01/2021 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 12/2017
2	Weight Gain 01/2021 - 09/2014
2	Chronic Renal Insufficiency 10/2019 - 01/2019
2	Birth Weight (Birth Weights) 03/2019 - 05/2014
2	Alzheimer Disease (Alzheimer's Disease) 04/2017 - 03/2012
2	Liver Neoplasms (Liver Cancer) 08/2016 - 03/2012
2	Overweight 01/2014 - 01/2013
2	Dysbiosis 10/2013 - 10/2013

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2008
10	CytokinesIBA 02/2022 - 02/2010
9	Pharmaceutical PreparationsIBA 06/2022 - 10/2008
7	Angiotensin IIIBA 01/2019 - 09/2008
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2018
6	Peptides (Polypeptides)IBA 04/2022 - 03/2006
6	Long Noncoding RNAIBA 10/2020 - 01/2016
5	Circular RNAIBA 06/2022 - 01/2020
5	Biological ProductsIBA 04/2022 - 10/2013
5	HydrogelsIBA 01/2022 - 11/2015
4	MetalsIBA 04/2022 - 03/2018
4	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2015
4	Messenger RNA (mRNA)IBA 10/2021 - 11/2006
4	CollagenIBA 01/2020 - 12/2016
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2019 - 08/2010
4	SuperantigensIBA 11/2011 - 11/2006
4	ExotoxinsIBA 11/2011 - 11/2006
3	SolutionsIBA 02/2022 - 10/2015
3	Competitive Endogenous RNAIBA 12/2021 - 01/2018
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2017
3	Losartan (Cozaar)FDA LinkGeneric 12/2019 - 11/2018
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019 - 02/2008
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 08/2010
3	ImmunosorbentsIBA 11/2011 - 01/2008
3	EnzymesIBA 11/2011 - 01/2008
2	SaltsIBA 02/2022 - 10/2015
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2008
2	AntigensIBA 10/2021 - 01/2021
2	AmmoniaIBA 05/2021 - 10/2013
2	LipopolysaccharidesIBA 02/2021 - 02/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2021 - 10/2008
2	CadmiumIBA 01/2021 - 11/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 10/2020
2	ChemokinesIBA 01/2021 - 12/2020
2	LigandsIBA 01/2021 - 03/2013
2	AngiotensinogenIBA 01/2021 - 12/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 08/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2019 - 11/2018
2	Ramipril (Altace)FDA LinkGeneric 10/2019 - 11/2018
2	Angiotensin Receptor AntagonistsIBA 10/2019 - 01/2014
2	Amino Acids FDA Link 01/2019 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2019
2	Phosphotransferases (Kinase)IBA 11/2018 - 10/2017
2	Hematoxylin (Haematoxylon)IBA 01/2018 - 06/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2018 - 06/2017
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2015 - 08/2015
2	Indicators and Reagents (Reagents)IBA 08/2015 - 01/2013
2	Minocycline (Cyclops)FDA LinkGeneric 01/2014 - 08/2010

Therapy/Procedure

16	Therapeutics 10/2022 - 10/2008
11	Drug Therapy (Chemotherapy) 06/2022 - 08/2012
3	Immunotherapy 04/2022 - 01/2020
3	Punctures 01/2019 - 03/2013
2	Enteral Nutrition (Feeding, Tube) 01/2022 - 01/2021
2	Oral Administration 12/2021 - 10/2019
2	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2019 - 07/2014
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 12/2016
2	Injections 09/2018 - 01/2016
2	Photothermal Therapy 12/2014 - 08/2012
2	Length of Stay 09/2014 - 03/2012